Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Quest Diagnostics Inc Lowers FY 2013 EPS Guidance; Lowers Low End Of Prior FY 2013 EPS Guidance To A Range In Line With Analysts' Estimates


Thursday, 18 Jul 2013 07:05am EDT 

Quest Diagnostics Inc announced that for fiscal 2013, it expects revenues to be 1% to 2% below the prior year, compared to previous guidance approximating the prior year leveland earnings per diluted share (EPS) to be between $4.35 and $4.50. The Company reported revenues of $7.382 billion in fiscal 2012. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $7.298 and EPS of $4.35 for fiscal 2013. 

Company Quote

64.44
0.62 +0.97%
1:36pm EST